Acomplia Pricing Likely To Follow Statin Model, Sanofi Says
Sanofi is likely to price the weight loss/smoking cessation agent Acomplia on par with the daily cost of statin therapy, the company suggested during an Aug. 31 analyst call
Sanofi is likely to price the weight loss/smoking cessation agent Acomplia on par with the daily cost of statin therapy, the company suggested during an Aug. 31 analyst call